Immix Biopharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $96 |
Gross Profit | -79 | -59 | 48 | |
EBITDA | -7,480 | -6,637 | -4,623 | -4,945 |
EBIT | -7,577 | -6,717 | -4,682 | -4,987 |
Net Income | -7,585 | -6,622 | -4,542 | -4,812 |
Net Change In Cash | 0 | 0 | 0 | 96 |
Free Cash Flow | -6,278 | -5,437 | -1,752 | -1,983 |
Cash | 15,947 | 11,637 | 15,921 | 17,681 |
Basic Shares | 31,926 | 29,983 | 29,701 | 27,540 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-89,517 | $0 |
Gross Profit | -115 | -5 | -89,519 | -2 |
EBITDA | -22,559 | -16,135 | -8,216 | -24,195 |
EBIT | -22,674 | -16,141 | -8,218 | -24,198 |
Net Income | -21,613 | -15,426 | -8,229 | -24,383 |
Net Change In Cash | 0 | 0 | -89,517 | 0 |
Free Cash Flow | -15,772 | -11,423 | -7,408 | -1,590 |
Cash | 17,681 | 17,509 | 13,436 | 17,644 |
Basic Shares | 28,285 | 17,341 | 13,887 | 3,672 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.24 |
2025-06-30 | -$0.22 |
2025-03-31 | -$0.15 |
